Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 10.68
+0.50 (4.91%)
Jul 31, 2026, 3:28 PM IST
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 2.06 billion as of July 31, 2026. Its market cap has decreased by -44.86% in one year.
Market Cap
2.06B
Enterprise Value
804.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.68
ChartMarket Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has decreased from 2.87B to 2.06B, a decrease of -28.27%. That is a compound annual growth rate of -1.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.06B | -52.78% |
| Dec 31, 2025 | 4.35B | -50.21% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.20B |
| Sigachi Industries | 9.91B |
| Bafna Pharmaceuticals | 5.98B |
| Valiant Laboratories | 3.35B |
| Brooks Laboratories | 1.76B |
| Alpa Laboratories | 1.43B |
| Balaxi Pharmaceuticals | 1.33B |
| Par Drugs and Chemicals | 1.18B |